BioPharmSignal logoBioPharmSignal

Biotech News

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Pulse Biosciences (PLSE)Pulse BiosciencesCompany update

Multicenter results show sustained high durability and procedural efficiency, redefining positive expectations for catheter ablation in patients with atrial fibrillation HAYWARD, Calif. --(BUSINESS WIRE)--Apr. 25, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology

Open original release

Related news

PLSEPulse Biosciences2026-04-07 11:00 EST

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

PLSEPulse Biosciences2026-03-17 11:00 EST

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

ANGOAngioDynamics2026-05-13 13:00 EST

AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer

HYPRHyperfine2026-06-18 12:15 EST

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

HYPRHyperfine2026-04-29 12:15 EST

Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution

View all latest news

Pulse Biosciences

Pulse Biosciences is a medical technology company focused on nano-pulse stimulation and nonthermal cellular treatments. Its platform is intended to create new ways to treat tissue while preserving surrounding structures.

Recent company news

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

PLSEPulse Biosciences2026-05-12 11:00 EST

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

PLSEPulse Biosciences2026-05-08 11:00 EST

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

PLSEPulse Biosciences2026-05-04 11:00 EST

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

PLSEPulse Biosciences2026-04-25 17:00 EST

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Stock data

Close
32.79 USD
Market cap
1.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States